Your browser doesn't support javascript.
loading
Younger patients and low c-peptide immunoreactivity index but not nutritional states affect fasting blood ketone levels in Japanese with type 1 diabetes after sodium-glucose cotransporter 2 inhibitor administration.
Nakajima, Hanako; Okada, Hiroshi; Yoshimura, Yuta; Tanaka, Toru; Hasegawa, Goji; Mitsuhashi, Kazuteru; Kitagawa, Noriyuki; Okamura, Takuro; Hashimoto, Yoshitaka; Senmaru, Takafumi; Ushigome, Emi; Nakanishi, Naoko; Yamazaki, Masahiro; Hamaguchi, Masahide; Fukui, Michiaki.
Afiliação
  • Nakajima H; Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.
  • Okada H; Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.
  • Yoshimura Y; Department of Endocrinology, Metabolism, and Diabetes, Saiseikai Suita Hospital, Osaka, Japan.
  • Tanaka T; Department of Diabetes and Endocrinology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
  • Hasegawa G; Division of Metabolism and Rheumatology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.
  • Mitsuhashi K; Department of Diabetes Internal Medicine, Fukuchiyama City Hospital, Kyoto, Japan.
  • Kitagawa N; Department of Diabetology, Kameoka Municipal Hospital, Kyoto, Japan.
  • Okamura T; Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.
  • Hashimoto Y; Department of Diabetes and Endocrinology, Matsushita Memorial Hospital, Moriguchi, Japan.
  • Senmaru T; Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.
  • Ushigome E; Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.
  • Nakanishi N; Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.
  • Yamazaki M; Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.
  • Hamaguchi M; Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.
  • Fukui M; Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.
Diabetes Obes Metab ; 25(12): 3682-3689, 2023 12.
Article em En | MEDLINE | ID: mdl-37667649
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 / Inibidores do Transportador 2 de Sódio-Glicose / Cetose Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 / Inibidores do Transportador 2 de Sódio-Glicose / Cetose Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article